Atlas Trials

Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil

Clinical trial NCT02822573 · COMPLETED

Trial details

NCT number
NCT02822573
Sponsor
Wake Forest University Health Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cognitive DysfunctionMemory Impairment
Start date
2017-05-30
Primary completion
2022-07-29
Enrollment
276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.